Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Transcode Therapeutics Inc (NQ: RNAZ ) 0.4546 -0.0154 (-3.28%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Transcode Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance November 05, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data October 23, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session October 10, 2024 Via Benzinga TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology October 10, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session October 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 03, 2024 Via Benzinga TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate September 17, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer September 10, 2024 Study demonstrates that TransCode’s lead therapeutic candidate, TTX-MC138, reduces tumor cell capacity for self-renewal From TransCode Therapeutics, Inc. Via GlobeNewswire TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate September 05, 2024 Grant awarded by the National Cancer Institute (NCI) of the NIH to support clinical development of lead therapeutic candidate, TTX-MC138 From TransCode Therapeutics, Inc. Via GlobeNewswire RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q2 2024 August 15, 2024 RNAZ stock results show that TransCode Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation August 15, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket July 29, 2024 Via Benzinga TransCode Therapeutics, Inc. Announces Closing of Public Offering July 24, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire Gold Moves Higher; Coca-Cola Increases FY24 Forecast July 23, 2024 Via Benzinga Why Transcode Therapeutics (RNAZ) Stock Is Down 60% July 23, 2024 Transcode Therapeutics shares are trading lower by 62% during Tuesday's session. The company announced pricing of its public offering. Via Benzinga Crude Oil Down 2%; GE Aerospace Earnings Top Views July 23, 2024 Via Benzinga Exposures Fossil Fuels US Stocks Edge Higher; General Motors Posts Upbeat Earnings July 23, 2024 Via Benzinga Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 23, 2024 Via Benzinga Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today? July 23, 2024 Mira Pharmaceuticals stock is falling on Tuesday but that's only after shares of MIRA underwent a massive rally on Monday. Via InvestorPlace Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today? July 23, 2024 TransCode Therapeutics stock is down on Tuesday after the biopharmaceutical company priced a public offering of RNAZ shares. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 23, 2024 Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning! Via InvestorPlace Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 23, 2024 Via Benzinga TransCode Therapeutics, Inc. Announces Pricing of Public Offering July 22, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock July 22, 2024 From TransCode Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session June 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session June 10, 2024 Via Benzinga Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements June 10, 2024 TransCode shares to remain listed on Nasdaq From TransCode Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session June 07, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
